| scholarly article | Q13442814 |
| P50 | author | Dominique Missiakas | Q96239604 |
| Olaf Schneewind | Q64624932 | ||
| Hwan Keun Kim | Q82211965 | ||
| P2093 | author name string | Andrea DeDent | |
| P2860 | cites work | The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b | Q21559500 |
| Structure of the cell wall anchor of surface proteins in Staphylococcus aureus | Q22299396 | ||
| The changing epidemiology of Staphylococcus aureus? | Q22305657 | ||
| LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity | Q24290410 | ||
| Hepcidin, a urinary antimicrobial peptide synthesized in the liver | Q24290609 | ||
| Haptoglobin: a natural bacteriostat | Q24302338 | ||
| Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization | Q24310115 | ||
| Fibrinogen substrate recognition by staphylocoagulase.(pro)thrombin complexes | Q24338455 | ||
| Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions | Q24338471 | ||
| Contribution of coagulases towards Staphylococcus aureus disease and protective immunity | Q27313924 | ||
| Structure of the fibrinogen γ-chain integrin binding and factor XIIIa cross-linking sites obtained through carrier protein driven crystallization | Q27620960 | ||
| Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation | Q27642265 | ||
| A Structural Model of the Staphylococcus aureus ClfA–Fibrinogen Interaction Opens New Avenues for the Design of Anti-Staphylococcal Therapeutics | Q27653017 | ||
| Characterization of staphyloferrin A biosynthetic and transport mutants in Staphylococcus aureus | Q27655314 | ||
| Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor | Q27655786 | ||
| Three-dimensional structure of the platelet integrin recognition segment of the fibrinogen gamma chain obtained by carrier protein-driven crystallization | Q27729409 | ||
| Staphylococcus aureus infections | Q28131787 | ||
| A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload | Q28139987 | ||
| Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein | Q28214986 | ||
| Direct thrombin inhibitors | Q28271181 | ||
| Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1 | Q28271523 | ||
| C3d of complement as a molecular adjuvant: bridging innate and acquired immunity | Q28272810 | ||
| Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b | Q28283397 | ||
| Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice | Q28586797 | ||
| Transfer of heme from heme-albumin to hemopexin | Q28678488 | ||
| Molecular characterization of the ferric-uptake regulator, fur, from Staphylococcus aureus | Q29346592 | ||
| Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron | Q29619561 | ||
| The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation | Q29620394 | ||
| A novel potent vasoconstrictor peptide produced by vascular endothelial cells | Q29620540 | ||
| Staphylococcus aureus IsdG and IsdI, heme-degrading enzymes with structural similarity to monooxygenases | Q30160416 | ||
| Staphylococcal vaccines and immunotherapy: to dream the impossible dream? | Q30355875 | ||
| Identification and characterization of a membrane permease involved in iron-hydroxamate transport in Staphylococcus aureus | Q30888761 | ||
| A novel von Willebrand factor binding protein expressed by Staphylococcus aureus | Q31095082 | ||
| Membrane damage elicits an immunomodulatory program in Staphylococcus aureus | Q33543122 | ||
| Complement evasion by human pathogens | Q33623972 | ||
| SirR, a novel iron-dependent repressor in Staphylococcus epidermidis | Q33761056 | ||
| Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model | Q33767412 | ||
| Staphylococcus aureus fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia | Q33769082 | ||
| A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo | Q33778077 | ||
| Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin | Q33818360 | ||
| Waves of resistance: Staphylococcus aureus in the antibiotic era. | Q33854398 | ||
| A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family | Q33896074 | ||
| Identification of the haemoglobin scavenger receptor. | Q33934404 | ||
| Sortase-catalysed anchoring of surface proteins to the cell wall of Staphylococcus aureus | Q33950921 | ||
| Immune evasion by staphylococci | Q33991798 | ||
| In Staphylococcus aureus, fur is an interactive regulator with PerR, contributes to virulence, and Is necessary for oxidative stress resistance through positive regulation of catalase and iron homeostasis | Q33995303 | ||
| Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets | Q34003911 | ||
| PerR controls oxidative stress resistance and iron storage proteins and is required for virulence in Staphylococcus aureus | Q34007737 | ||
| An iron-regulated sortase anchors a class of surface protein during Staphylococcus aureus pathogenesis | Q34013120 | ||
| Cross-link in fibrin polymerized by factor 13: epsilon-(gamma-glutamyl)lysine | Q34053195 | ||
| Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. | Q34058113 | ||
| Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen | Q34065001 | ||
| Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus | Q34067024 | ||
| Tissue factor on the loose | Q34090266 | ||
| Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice | Q34096536 | ||
| Body iron exchange in man. | Q34098726 | ||
| Role of Iron in Bacterial Infection | Q34182281 | ||
| Allosteric inhibition of complement function by a staphylococcal immune evasion protein | Q34200056 | ||
| Specificity of Staphyloferrin B Recognition by the SirA Receptor from Staphylococcus aureus | Q34251178 | ||
| AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER. | Q34257237 | ||
| WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. | Q34257361 | ||
| Iron withholding: a defense against infection and neoplasia | Q34259767 | ||
| White thromboembolism in the hamster cheek pouch after trauma, infection and neoplasia | Q34296162 | ||
| The crisis in antibiotic resistance | Q34314442 | ||
| A widely distributed bacterial pathway for siderophore biosynthesis independent of nonribosomal peptide synthetases | Q34395738 | ||
| What determines nasal carriage of Staphylococcus aureus? | Q34453451 | ||
| A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model | Q34492730 | ||
| Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning | Q37034077 | ||
| Blood-borne tissue factor: another view of thrombosis | Q37181879 | ||
| Serologic assay to quantify human immunoglobulin G antibodies to the Staphylococcus aureus iron surface determinant B antigen | Q37190930 | ||
| Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin | Q37194661 | ||
| Subcellular localization of the Staphylococcus aureus heme iron transport components IsdA and IsdB. | Q37256491 | ||
| Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues | Q37355394 | ||
| Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes. | Q37388757 | ||
| Staphylococcus aureus synthesizes adenosine to escape host immune responses | Q37402368 | ||
| Interferon-gamma in the management of chronic granulomatous disease. | Q37557418 | ||
| Review article: Coagulation cascade and therapeutics update: relevance to nephrology. Part 1: Overview of coagulation, thrombophilias and history of anticoagulants. | Q37578743 | ||
| Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion | Q37697201 | ||
| Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus | Q38295023 | ||
| Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus. | Q38334334 | ||
| The von Willebrand factor-binding protein (vWbp) of Staphylococcus aureus is a coagulase | Q38341380 | ||
| IsdG and IsdI, heme-degrading enzymes in the cytoplasm of Staphylococcus aureus | Q38348894 | ||
| Identification and characterization of fhuD1 and fhuD2, two genes involved in iron-hydroxamate uptake in Staphylococcus aureus. | Q39504510 | ||
| Receptor-mediated recognition and uptake of iron from human transferrin by Staphylococcus aureus and Staphylococcus epidermidis | Q39572195 | ||
| Mutational analyses reveal that the staphylococcal immune evasion molecule Sbi and complement receptor 2 (CR2) share overlapping contact residues on C3d: implications for the controversy regarding the CR2/C3d cocrystal structure. | Q39750608 | ||
| Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads | Q39827332 | ||
| The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. | Q39831208 | ||
| Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis | Q39896801 | ||
| Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores | Q39954600 | ||
| The role of coagulase in staphylococcal infections | Q39961324 | ||
| Binding of immunoglobulins to protein A and immunoglobulin levels in mammalian sera | Q40153929 | ||
| Studies on staphylococci. II. Effect of coagulase on the virulence of coagulase negative strains. | Q40433860 | ||
| Involvement of SirABC in iron-siderophore import in Staphylococcus aureus | Q40535930 | ||
| Effect of highly purified coagulase and culture filtrate on virulence and immunity of a coagulase-negative mutant of staphylococcus aureus BB. | Q40600451 | ||
| Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. | Q40918234 | ||
| Plasma and red cell iron turnover in normal subjects and in patients having various hematopoietic disorders | Q40979485 | ||
| The Influence of certain Bacteria on the Coagulation of the Blood. | Q41036958 | ||
| Identification of the Staphylococcus aureus MSCRAMM clumping factor B (ClfB) binding site in the alphaC-domain of human fibrinogen | Q41066583 | ||
| Activation of a pro-enzyme by a stoichiometric reaction with another protein. The reaction between prothrombin and staphylocoagulase | Q41067903 | ||
| Region X, the cell-wall-attachment part of staphylococcal protein A. | Q41593374 | ||
| Dabigatran Inhibits Staphylococcus aureus Coagulase Activity | Q42036878 | ||
| The involvement of lactoferrin in the hyposideremia of acute inflammation | Q42091283 | ||
| Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. | Q42110792 | ||
| Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs | Q42146910 | ||
| Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation | Q42828955 | ||
| Selection and characterization of murine monoclonal antibodies to Staphylococcus aureus iron-regulated surface determinant B with functional activity in vitro and in vivo. | Q43071917 | ||
| Demonstration of the iron-regulated surface determinant (Isd) heme transfer pathway in Staphylococcus aureus. | Q43156017 | ||
| Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms | Q43508044 | ||
| Virulence of coagulase-deficient mutants of Staphylococcus aureus in experimental endocarditis | Q43543736 | ||
| Identification and characterization of the Staphylococcus aureus gene cluster coding for staphyloferrin A. | Q43622052 | ||
| Expression and function of adenosine receptors in human dendritic cells | Q43726407 | ||
| Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro | Q34569233 | ||
| Genetics and assembly line enzymology of siderophore biosynthesis in bacteria | Q34647692 | ||
| S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation | Q34722335 | ||
| Mechanisms of thrombus formation | Q34815800 | ||
| Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation | Q34859818 | ||
| Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A. | Q34944592 | ||
| Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia | Q34973729 | ||
| IsdA and IsdB antibodies protect mice against Staphylococcus aureus abscess formation and lethal challenge | Q34983585 | ||
| Staphylococcus aureus transporters Hts, Sir, and Sst capture iron liberated from human transferrin by Staphyloferrin A, Staphyloferrin B, and catecholamine stress hormones, respectively, and contribute to virulence | Q35075837 | ||
| Activation of a Proteolytic System by a Membrane Lipoprotein: Mechanism of Action of Tissue Factor | Q35094854 | ||
| Vaccine assembly from surface proteins of Staphylococcus aureus. | Q35130822 | ||
| In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation | Q35204647 | ||
| Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization. | Q35220663 | ||
| Identifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responses | Q35225082 | ||
| Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis | Q35455244 | ||
| Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials | Q35710192 | ||
| A B cell superantigen-induced persistent "Hole" in the B-1 repertoire | Q35834654 | ||
| A Staphylococcus aureus regulatory system that responds to host heme and modulates virulence | Q36154241 | ||
| Role of siderophore biosynthesis in virulence of Staphylococcus aureus: identification and characterization of genes involved in production of a siderophore | Q36227179 | ||
| Staphylococcal complement evasion by various convertase-blocking molecules. | Q36228970 | ||
| The ingestion and digestion of human lactoferrin by mouse peritoneal macrophages and the transfer of its iron into ferritin | Q36335854 | ||
| Molecular insights into the pathogenesis of hereditary haemochromatosis | Q36419082 | ||
| Neutrophils Influence the Level of Antigen Presentation during the Immune Response to Protein Antigens in Adjuvants | Q36432999 | ||
| Community-associated meticillin-resistant Staphylococcus aureus | Q36438720 | ||
| Specific inhibition of Escherichia coli ferrienterochelin uptake by a normal human serum immunoglobulin. | Q36442492 | ||
| Direct hemin transfer from IsdA to IsdC in the iron-regulated surface determinant (Isd) heme acquisition system of Staphylococcus aureus | Q36658328 | ||
| Staphylococcus aureus HrtA is an ATPase required for protection against heme toxicity and prevention of a transcriptional heme stress response. | Q36672835 | ||
| Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity | Q36751636 | ||
| Association of hemochromatosis with infectious diseases: expanding spectrum | Q36864775 | ||
| Anti-Clumping Factor A Immunoglobulin Reduces the Duration of Methicillin-ResistantStaphylococcus aureusBacteremia in an Experimental Model of Infective Endocarditis | Q36880839 | ||
| Passage of heme-iron across the envelope of Staphylococcus aureus. | Q44307087 | ||
| Identification of a novel iron regulated staphylococcal surface protein with haptoglobin-haemoglobin binding activity | Q44927238 | ||
| Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobuli | Q44983018 | ||
| Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection | Q45733086 | ||
| Age-associated changes in binding of human B lymphocytes to a VH3-restricted unconventional bacterial antigen | Q45932908 | ||
| Effect of the introduction of 'Healthy Start' on dietary behaviour during and after pregnancy: early results from the 'before and after' Sheffield study | Q46239758 | ||
| Recent Advances in Haptoglobin and Transferrin Genetics | Q46309895 | ||
| Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus. | Q46838216 | ||
| Heme binding properties of Staphylococcus aureus IsdE. | Q46955356 | ||
| In vivo heme scavenging by Staphylococcus aureus IsdC and IsdE proteins | Q47234779 | ||
| Evolution of type-specific immunoassays to evaluate the functional immune response to Gardasil: a vaccine for human papillomavirus types 16, 18, 6 and 11. | Q47794837 | ||
| Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus | Q48086155 | ||
| The coagulase of Staphylococcus aureus 8325-4. Sequence analysis and virulence of site-specific coagulase-deficient mutants | Q48273054 | ||
| Nucleotide sequence of the staphylocoagulase gene: its unique COOH-terminal 8 tandem repeats | Q48335846 | ||
| Staphylococcal coagulase; mode of action and antigenicity. | Q51043511 | ||
| Dependence of germinal center B cells on expression of CD21/CD35 for survival. | Q52039603 | ||
| The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria | Q52841509 | ||
| MntR modulates expression of the PerR regulon and superoxide resistance in Staphylococcus aureus through control of manganese uptake. | Q53970053 | ||
| Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. | Q53979462 | ||
| The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States. | Q54417681 | ||
| Molecular cloning and expression of the coagulase gene of Staphylococcus aureus 8325-4. | Q54755609 | ||
| Iron acquisition by the haem-binding Isd proteins inStaphylococcus aureus: studies of the mechanism using magnetic circular dichroism | Q58051148 | ||
| Repetitive Sequences in Protein A from Staphylococcus aureus. Arrangement of Five Regions within the Protein, Four being Highly Homologous and Fc-Binding | Q67010897 | ||
| Binding of glycoprotein IIIa-derived peptide 217-231 to fibrinogen and von Willebrand factors and its inhibition by platelet glycoprotein IIb/IIIa complex | Q68073842 | ||
| Interaction of fibrinogen with its platelet receptor. Differential effects of alpha and gamma chain fibrinogen peptides on the glycoprotein IIb-IIIa complex | Q68506495 | ||
| Human IgM molecules that bind staphylococcal protein A contain VHIII H chains | Q69187430 | ||
| Altered virulence of a pleiotropic Staphylococcus aureus mutant with a low producibility of coagulase and other factors in mice | Q69443479 | ||
| Antithrombotic activity of glomerular adenosine diphosphatase in the glomerular basement membrane of the rat kidney | Q70161979 | ||
| Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor | Q70237272 | ||
| Identification of a region of human fibrinogen interacting with staphylococcal clumping factor | Q70331710 | ||
| Isolation, characterization, and synthesis of peptides from human fibrinogen that block the staphylococcal clumping reaction and construction of a synthetic clumping particle | Q70331714 | ||
| Relationship among plasma iron, plasma iron turnover, and reticuloendothelial iron release | Q70427591 | ||
| Pulmonary neutrophil kinetics after thrombin-induced intravascular coagulation | Q70502151 | ||
| Staphylocoagulase | Q70873635 | ||
| Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator | Q71235444 | ||
| Effect of the carbocyclic nucleoside analogue MDL 201,112 on inhibition of interferon-gamma-induced priming of Lewis (LEW/N) rat macrophages for enhanced respiratory burst and MHC class II Ia+ antigen expression | Q72153007 | ||
| Protein A is the von Willebrand factor binding protein on Staphylococcus aureus | Q74296184 | ||
| Iron-source preference of Staphylococcus aureus infections | Q80551515 | ||
| Signaling and DNA-binding activities of the Staphylococcus aureus HssR-HssS two-component system required for heme sensing | Q80628132 | ||
| Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants | Q80844725 | ||
| Direct interaction of iron-regulated surface determinant IsdB of Staphylococcus aureus with the GPIIb/IIIa receptor on platelets | Q82231973 | ||
| Polymorphonuclear neutrophils deliver activation signals and antigenic molecules to dendritic cells: a new link between leukocytes upstream of T lymphocytes | Q82660148 | ||
| Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage | Q82862847 | ||
| P433 | issue | 2 | |
| P921 | main subject | Staphylococcus aureus | Q188121 |
| P304 | page(s) | 317-333 | |
| P577 | publication date | 2011-12-01 | |
| P1433 | published in | Seminars in Immunopathology | Q15724576 |
| P1476 | title | Exploring Staphylococcus aureus pathways to disease for vaccine development | |
| P478 | volume | 34 |
| Q36277405 | Abscess formation and alpha-hemolysin induced toxicity in a mouse model of Staphylococcus aureus peritoneal infection. |
| Q41204924 | Adjuvant-dependent immunogenicity of Staphylococcus aureus Efb and Map proteins in chickens. |
| Q50116528 | Altered immune proteome of Staphylococcus aureus under iron-restricted growth conditions |
| Q35765208 | Attenuation of Staphylococcus aureus-Induced Bacteremia by Human Mini-Antibodies Targeting the Complement Inhibitory Protein Efb |
| Q36277411 | Coagulases as determinants of protective immune responses against Staphylococcus aureus |
| Q57072739 | Essential Domain-Dependent Roles Within Soluble IgG for Superantigen Properties of Staphylococcal Protein A: Resolving the B-Cell Superantigen Paradox |
| Q35063930 | Evaluation of the protective immunity of a novel subunit fusion vaccine in a murine model of systemic MRSA infection |
| Q59806683 | Models matter: the search for an effective Staphylococcus aureus vaccine |
| Q38207403 | Mouse models for infectious diseases caused by Staphylococcus aureus. |
| Q93220831 | PPE37 Is Essential for Mycobacterium tuberculosis Heme-Iron Acquisition (HIA), and a Defective PPE37 in Mycobacterium bovis BCG Prevents HIA |
| Q35069186 | Phagocytosis escape by a Staphylococcus aureus protein that connects complement and coagulation proteins at the bacterial surface |
| Q36277427 | Protein A-specific monoclonal antibodies and prevention of Staphylococcus aureus disease in mice |
| Q38037549 | The iron-regulated staphylococcal lipoproteins. |
| Q30415990 | The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections |
| Q36368669 | Vaccination with a UV-irradiated genetically attenuated mutant of Staphylococcus aureus provides protection against subsequent systemic infection. |
| Q34596203 | Vaccine protection of leukopenic mice against Staphylococcus aureus bloodstream infection |
| Q26828726 | Where does a Staphylococcus aureus vaccine stand? |
Search more.